Candel Therapeutics (CADL) Free Cash Flow (2020 - 2023)
Historic Free Cash Flow for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to -$7.5 million.
- Candel Therapeutics' Free Cash Flow fell 430.11% to -$7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.7 million, marking a year-over-year decrease of 606.74%. This contributed to the annual value of -$27.0 million for FY2024, which is 2208.01% up from last year.
- Per Candel Therapeutics' latest filing, its Free Cash Flow stood at -$7.5 million for Q4 2023, which was down 430.11% from -$8.9 million recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Free Cash Flow ranged from a high of -$2.2 million in Q3 2020 and a low of -$11.0 million during Q1 2023
- In the last 4 years, Candel Therapeutics' Free Cash Flow had a median value of -$7.4 million in 2023 and averaged -$7.0 million.
- In the last 5 years, Candel Therapeutics' Free Cash Flow tumbled by 19641.42% in 2021 and then skyrocketed by 716.74% in 2023.
- Over the past 4 years, Candel Therapeutics' Free Cash Flow (Quarter) stood at -$3.9 million in 2020, then plummeted by 48.41% to -$5.7 million in 2021, then dropped by 24.71% to -$7.2 million in 2022, then decreased by 4.3% to -$7.5 million in 2023.
- Its Free Cash Flow was -$7.5 million in Q4 2023, compared to -$8.9 million in Q3 2023 and -$7.4 million in Q2 2023.